A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
Study sponsor: Krystal Biotech, Inc. · KRYS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-07-31Actual
Enrollment · participants47Actual
Source updated2024-04-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.